Form 8-K - Current report:
SEC Accession No. 0001193125-25-137810
Filing Date
2025-06-09
Accepted
2025-06-09 16:05:52
Documents
12
Period of Report
2025-06-05
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d935876d8k.htm   iXBRL 8-K 32561
  Complete submission text file 0001193125-25-137810.txt   149777

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA annx-20250605.xsd EX-101.SCH 2847
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE annx-20250605_lab.xml EX-101.LAB 18757
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE annx-20250605_pre.xml EX-101.PRE 11708
14 EXTRACTED XBRL INSTANCE DOCUMENT d935876d8k_htm.xml XML 3768
Mailing Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005
Business Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005 (650)-822-5500
Annexon, Inc. (Filer) CIK: 0001528115 (see all company filings)

EIN.: 275414423 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39402 | Film No.: 251034052
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)